Mark J. Bluth

3.0k total citations · 2 hit papers
27 papers, 2.0k citations indexed

About

Mark J. Bluth is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mark J. Bluth has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Mark J. Bluth's work include Cancer Immunotherapy and Biomarkers (9 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Immunotherapy and Immune Responses (4 papers). Mark J. Bluth is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Immunotherapy and Immune Responses (4 papers). Mark J. Bluth collaborates with scholars based in United States, Switzerland and Saudi Arabia. Mark J. Bluth's co-authors include James G. Krueger, Mayte Suárez‐Fariñas, Michelle A. Lowes, Judilyn Fuentes‐Duculan, Irma Cardinale, Lisa C. Zaba, Artemis Khatcherian, Inna Novitskaya, Patricia Gilleaudeau and Mary Sullivan‐Whalen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Mark J. Bluth

26 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

2007 540 citations Lisa C. Zaba, Irma Cardinale et al. The Journal of Experimental Medicine profile →
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

2018 374 citations Min Yuen Teo, Kenneth Seier et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Bluth United States	15	1.0k	960	517	338	270	27	2.0k
Puthiyaveettil N. Raghunath United States	22	795 0.8×	904 0.9×	948 1.8×	138 0.4×	262 1.0×	37	2.4k
Chris Morehouse United States	24	1.0k 1.0×	477 0.5×	580 1.1×	178 0.5×	137 0.5×	42	2.2k
Eva Geissinger Germany	27	653 0.7×	874 0.9×	599 1.2×	576 1.7×	339 1.3×	79	2.3k
A. Hafeez Diwan United States	24	225 0.2×	715 0.7×	580 1.1×	462 1.4×	224 0.8×	83	1.7k
Carmen Bellas Spain	22	933 0.9×	647 0.7×	318 0.6×	116 0.3×	147 0.5×	59	1.9k
Barbara Bigerna Italy	23	661 0.7×	664 0.7×	876 1.7×	173 0.5×	153 0.6×	35	2.5k
Imke Satzger Germany	26	334 0.3×	1.2k 1.2×	595 1.2×	332 1.0×	205 0.8×	55	1.8k
Monika Kasprzycka Poland	19	521 0.5×	361 0.4×	405 0.8×	149 0.4×	185 0.7×	35	1.2k
Patricia Bourne United States	22	408 0.4×	529 0.6×	552 1.1×	75 0.2×	424 1.6×	46	1.7k
Mamiko Sakata‐Yanagimoto Japan	25	620 0.6×	624 0.7×	719 1.4×	105 0.3×	98 0.4×	96	2.0k

Countries citing papers authored by Mark J. Bluth

Since Specialization

Citations

This map shows the geographic impact of Mark J. Bluth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Bluth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Bluth more than expected).

Fields of papers citing papers by Mark J. Bluth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Bluth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Bluth. The network helps show where Mark J. Bluth may publish in the future.

Co-authorship network of co-authors of Mark J. Bluth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Bluth. A scholar is included among the top collaborators of Mark J. Bluth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Bluth. Mark J. Bluth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bluth, Mark J., et al.. (2022). Moesin: A novel receptor on NK lymphocytes binds to TOMM40 on K562 leukemia cells initiating cytolysis. Human Immunology. 83(5). 418–427. 3 indexed citations

Bluth, Mark J., et al.. (2018). Molecular Pathology Techniques. Clinics in Laboratory Medicine. 38(2). 215–236. 9 indexed citations

Teo, Min Yuen, Kenneth Seier, Irina Ostrovnaya, et al.. (2018). Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers. Journal of Clinical Oncology. 36(17). 1685–1694. 374 indexed citations breakdown →

D’Angelo, Sandra P., Alexander N. Shoushtari, Mary Louise Keohan, et al.. (2016). Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clinical Cancer Research. 23(12). 2972–2980. 98 indexed citations

Abdel‐Wahab, Omar, Virginia M. Klimek, Agnès Viale, et al.. (2014). Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies. Cancer Discovery. 4(5). 538–545. 59 indexed citations

Shoushtari, Alexander N., Mark J. Bluth, Gauri Bhuchar, et al.. (2014). The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma.. Journal of Clinical Oncology. 32(15_suppl). 9073–9073. 2 indexed citations

Bluth, Mark J., et al.. (2013). Molecular Pathology Techniques. Clinics in Laboratory Medicine. 33(4). 753–772. 6 indexed citations

Postow, Michael A., Jason J. Luke, Mark J. Bluth, et al.. (2013). Ipilimumab for Patients With Advanced Mucosal Melanoma. The Oncologist. 18(6). 726–732. 116 indexed citations

Fujita, Hideki, Mayte Suárez‐Fariñas, Hiroshi Mitsui, et al.. (2012). Langerhans Cells from Human Cutaneous Squamous Cell Carcinoma Induce Strong Type 1 Immunity. Journal of Investigative Dermatology. 132(6). 1645–1655. 36 indexed citations

10.

Khan, Shaheer, Margaret K. Callahan, Michael A. Postow, et al.. (2012). Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience.. Journal of Clinical Oncology. 30(15_suppl). 8549–8549. 15 indexed citations

11.

Carvajal, Richard D., Grazia Ambrosini, Jedd D. Wolchok, et al.. (2012). Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma.. Journal of Clinical Oncology. 30(15_suppl). 8598–8598. 5 indexed citations

12.

Bluth, Mark J., et al.. (2012). Ruptured dermoid cyst arising from Meckel cave. Neurology Clinical Practice. 2(1). 83–84. 1 indexed citations

13.

Fuentes‐Duculan, Judilyn, Mayte Suárez‐Fariñas, Katherine C. Pierson, et al.. (2011). Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated. Journal of Investigative Dermatology. 131(6). 1322–1330. 163 indexed citations

14.

Bluth, Martin H., et al.. (2011). Peripheral blood mononuclear cell gene array profiles in female patients with involuntary bladder contractions. 3–3.

15.

Moussai, Dariush, Hiroshi Mitsui, Katherine C. Pierson, et al.. (2010). The Human Cutaneous Squamous Cell Carcinoma Microenvironment Is Characterized by Increased Lymphatic Density and Enhanced Expression of Macrophage-Derived VEGF-C. Journal of Investigative Dermatology. 131(1). 229–236. 92 indexed citations

16.

Bluth, Mark J., et al.. (2009). Peripheral Blood Mononuclear Cell Gene Array Profiles in Patients With Overactive Bladder. Urology. 75(4). 896–901. 10 indexed citations

17.

Bluth, Mark J., Lisa C. Zaba, Dariush Moussai, et al.. (2009). Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation. Journal of Investigative Dermatology. 129(10). 2451–2462. 77 indexed citations

18.

Zaba, Lisa C., Irma Cardinale, Patricia Gilleaudeau, et al.. (2008). Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. The Journal of Experimental Medicine. 205(8). 1941–1941. 16 indexed citations

19.

Zaba, Lisa C., Irma Cardinale, Patricia Gilleaudeau, et al.. (2007). Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. The Journal of Experimental Medicine. 204(13). 3183–3194. 540 indexed citations breakdown →

20.

Jeret, Joseph S. & Mark J. Bluth. (2002). Stroke following Chiropractic Manipulation. Cerebrovascular Diseases. 13(3). 210–213. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact